Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,444,785
+$1,216,955 QoQ
Shares Held
113,575
-1.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#209
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. NVO ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,905 | $17,842,534 | |
| 2 | LLY |
ELI LILLY & Co
|
12,084 | $14,493,913 | |
| 3 | JNJ |
Johnson & Johnson
|
23,321 | $5,922,834 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
113,575 | $5,444,785 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,742 | $346,424 | |
| 6 | AZN |
Astrazeneca PLC
|
1,412 | $267,743 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,014 | $258,799 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,444,785 | 113,575 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,227,830 | 115,043 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,466,746 | 127,098 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,126,136 | 128,422 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,870,105 | 128,515 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,955,495 | 200,972 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $16,971,401 | 197,296 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,973,791 | 201,342 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $28,729,565 | 201,272 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,606,940 | 199,431 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,457,649 | 236,420 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,994,384 | 241,856 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,926,232 | 110,772 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,345,197 | 90,142 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $12,411,625 | 91,707 | Shares | Sole | 2023-03-24 | |
| 2022-09-30 | $9,166,358 | 92,004 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,014,214 | 89,870 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,936,642 | 89,479 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $9,991,744 | 89,212 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $8,555,643 | 89,112 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,464,912 | 89,112 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $6,093,891 | 90,387 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,313,531 | 90,387 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,253,907 | 90,075 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,898,111 | 90,075 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $5,440,575 | 90,375 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||